Nr508 pharm - Study guides, Class notes & Summaries

NR 508 NR508 ADVANCED PHARM MIDTERM QUESTIONS AND ANSWERS EXAM 3 GRADED A 2022/2023 A patient who has primary hyperlipidemia and who takes atorvastatin (Lipitor) continues to have LDL cholesterol of 140 mg/dL after 3 months of therapy. The primary care NP increases the dose from 10 mg daily to 20 mg daily. The patient reports headache and dizziness a few weeks after the dose increase. The NP should: change the atorvastatin dose to 15 mg twice daily. change the patient’s medic...

NR508 Advanced Pharmacology Final Exam Test Bank 1. Nurse practitioner prescriptive authority is regulated by: 1 The National Council of State Boards of Nursing . 2 The U.S. Drug Enforcement Administration . 3 The State Board of Nursing for each state . 4 The State Board of Pharmacy . 2.The benefits to the patient of having anAdvanced Practice Registered Nurse (APRN) prescriber include: 1. Nurses know more about Pharmacology than other prescribers because they take it both in their b...

NR508 ADVANCED PHARM POSSIBLE MIDTERM QUESTIONS AND ANSWERS EXAM 3   NR508 ADVANCED PHARM POSSIBLE MIDTERM QUESTIONS AND ANSWERS EXAM 3 A patient who has primary hyperlipidemia and who takes atorvastatin (Lipitor) continues to have LDL cholesterol of 140 mg/dL after 3 months of therapy. The primary care NP increases the dose from 10 mg daily to 20 mg daily. The patient reports headache and dizziness a few weeks after the dose increase. The NP should: change the atorvastatin...

A patient who has primary hyperlipidemia and who takes atorvastatin (Lipitor) continues to have LDL cholesterol of 140 mg/dL after 3 months of therapy. The primary care NP increases the dose from 10 mg daily to 20 mg daily. The patient reports headache and dizziness a few weeks after the dose increase. The NP should: change the atorvastatin dose to 15 mg twice daily. change the patient’s medication to cholestyramine (Questran). Correct! add ezetimibe (Zetia) and lower the atorvastatin to...

NR508 Week 4-Midterm Roles and Responsibilities of APRN 1. All states have title protection for NP 2. All but 5 states stat's board of nursing control practice and licensure. 3. Scope of practice determined by individual NP license of licensing jurisdiction.New prescribers must know the rules 4. in 17 states, NPs have independent scope of practice and prescriptive authority. 5.6 states have full autonomous practice and prescriptive authority. Clinical Judgement in prescribing 1. Best ...

A patient who has primary hyperlipidemia and who takes atorvastatin (Lipitor) continues to have LDL cholesterol of 140 mg/dL after 3 months of therapy. The primary care NP increases the dose from 10 mg daily to 20 mg daily. The patient reports headache and dizziness a few weeks after the dose increase. The NP should: change the atorvastatin dose to 15 mg twice daily. change the patient’s medication to cholestyramine (Questran). Correct! add ezetimibe (Zetia) and lower the atorvastatin to...

NR 508 PHARM MIDTERM EXAM / NR508 PHARM MIDTERM EXAM:NEWEST-2022NR 508 PHARM MIDTERM EXAM / NR508 PHARM MIDTERM EXAM:NEWEST-2022NR 508 PHARM MIDTERM EXAM / NR508 PHARM MIDTERM EXAM:NEWEST-2022

NR 508 PHARM MIDTERM STUDY GUIDE / NR508 PHARM MIDTERM STUDY GUIDE:NEWEST-2022NR 508 PHARM MIDTERM STUDY GUIDE / NR508 PHARM MIDTERM STUDY GUIDE:NEWEST-2022NR 508 PHARM MIDTERM STUDY GUIDE / NR508 PHARM MIDTERM STUDY GUIDE:NEWEST-2022

A patient who has primary hyperlipidemia and who takes atorvastatin (Lipitor) continues to have LDL cholesterol of 140 mg/dL after 3 months of therapy. The primary care NP increases the dose from 10 mg daily to 20 mg daily. The patient reports headache and dizziness a few weeks after the dose increase. The NP should: change the atorvastatin dose to 15 mg twice daily. change the patient’s medication to cholestyramine (Questran). add ezetimibe (Zetia) and lower the atorvastatin to 10 mg...